edward jones dsip Our History | Edward Jones

The enhanced antimicrobial performance is attributed to the synergistic interaction between the biopolymeric matrix and the porous MOF structure, which facilitates sustained Cu release and effective disruption of microbial membrane

Regulation of radial glial survival by signals from the meninges

Lung Cell

In the United States, the Food and Drug Administration (FDA) classified BPC-157 as Category 2 for compounding due to adverse immune system reactions, peptide-related impurities and insufficient safety information to determine whether it would cause harm when administered to humans

Novo Nordisk filed for FDA approval of CagriSema in early 2026, with a review decision expected later this year